Cancer of unknown primary (CUP) is a rare malignancy that presents with metastatic disease and no identifiable site of origin. Most patients have unfavorable features and …
Z Gatalica, J Xiu, J Swensen, S Vranic - European journal of cancer, 2018 - Elsevier
Background Cancer of unknown primary (CUP) accounts for approximately 3% of all malignancies. Avoiding immune destruction is a major cancer characteristic and therapies …
E Rassy, P Parent, F Lefort, S Boussios… - Critical reviews in …, 2020 - Elsevier
Abstract Cancers of Unknown Primary Site (CUP) account for approximately 1–3% of all malignant neoplasms. It represents a heterogeneous group of malignancies without a …
T Olivier, E Fernandez, I Labidi-Galy, PY Dietrich… - Cancer treatment …, 2021 - Elsevier
The concept of Cancer of Unknown Primary (CUP) has evolved with the advent of medical oncology. CUP can be difficult to diagnose and represents 2 to 5% of new cancers, therefore …
Simple Summary Patients with cancer of unknown primary site suffer the burden of an uncertain disease, which is characterized by the impossibility to identify the tissue where the …
S Kolling, F Ventre, E Geuna, M Milan… - Frontiers in …, 2020 - frontiersin.org
Cancer of unknown primary (CUP) is an umbrella term used to classify a heterogeneous group of metastatic cancers based on the absence of an identifiable primary tumor …
Z Gatalica, SZ Millis, S Vranic, R Bender, GD Basu… - Oncotarget, 2014 - ncbi.nlm.nih.gov
Background Cancer of unknown primary (CUP) accounts for approximately 3% of all malignancies. Despite extensive laboratory and imaging efforts, the primary site usually …
LJ Schipper, KG Samsom, P Snaebjornsson… - ESMO open, 2022 - Elsevier
Background In∼ 3%-5% of patients with metastatic disease, tumor origin remains unknown despite modern imaging techniques and extensive pathology work-up. With long diagnostic …
JD Hainsworth, FA Greco - Virchows Archiv, 2014 - Springer
Carcinoma of unknown primary site (CUP) is diagnosed in approximately 3% of patients with advanced cancer, and most patients have traditionally been treated with empiric …